Pharmacologic Characteristics of Indinavir, Didanosine, and Stavudine in Human Immunodeficiency Virus-Infected Children Receiving Combination Therapy

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antimicrobial Agents and Chemotherapy 2000-04, Vol.44 (4), p.1029-1034
Hauptverfasser:	FLETCHER, C. V, BRUNDAGE, R. C, REMMEL, R. P, PAGE, L. M, WELLER, D, CALLES, N. R, SIMON, C, KLINE, M. W
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-HIV Agents Anti-HIV Agents - pharmacokinetics Anti-HIV Agents - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Area Under Curve Biological and medical sciences Child Chromatography, High Pressure Liquid Didanosine Didanosine - pharmacokinetics Didanosine - therapeutic use Drug Therapy, Combination Half-Life HIV Infections HIV Infections - drug therapy HIV Infections - metabolism HIV Infections - virology Human immunodeficiency virus Humans Indinavir Indinavir - pharmacokinetics Indinavir - therapeutic use Medical sciences Pharmacology Pharmacology. Drug treatments Spectrophotometry, Ultraviolet Stavudine Stavudine - pharmacokinetics Stavudine - therapeutic use Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!